Citius Pharmaceuticals (NASDAQ: CTXR)
$1.29
(-5.8%)
-$0.08
Price as of August 1, 2025, 4:00 p.m. ET
Citius Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Citius Pharmaceuticals Company Info
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
News & Analysis
Featured Article
Could Citius Pharmaceuticals Be a Millionaire-Maker Stock?
A lot would have to go right for this biotech to make investors rich.
Alex Carchidi | Jul 20, 2021
Featured Article
Here's Why Citius Pharmaceuticals Stock Is Losing Ground Today
Another interim analysis has come and gone with an unsatisfying result.
Cory Renauer | Jul 1, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.